HAEMONETICS CORP - Director's Dealing 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2016-08-05

Reporting Person: FOOTE SUSAN BARTLETT (Director)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-05	Common Stock	S	300	$35.355	Disposed	16311	Direct
2016-08-05	Common Stock	S	8280	$35.35	Disposed	16611	Direct
2016-08-05	Common Stock	M	8580	$27.24	Acquired	24891	Direct
2016-08-05	Common Stock	S	5305	$35.35	Disposed	16311	Direct
2016-08-05	Common Stock	S	200	$35.346	Disposed	21616	Direct
2016-08-05	Common Stock	S	300	$35.34	Disposed	21816	Direct
2016-08-05	Common Stock	S	200	$35.33	Disposed	22116	Direct
2016-08-05	Common Stock	S	100	$35.32	Disposed	22316	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-05	Non-qualified Stock Option (Right to Buy)	$27.24	M	8580	Disposed	2017-07-29	Common Stock (8580)	Direct

F1: Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.